Medical Use
Monjuvi is a CD19-directed cytolytic antibody used alongside lenalidomide to treat adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), including DLBCL arising from low-grade lymphoma, who are not eligible for autologous stem cell transplant (ASCT).
Recommended Dosage: The recommended dosage is 12 mg/kg administered as an intravenous infusion according to the following schedule:
- -Cycle 1: Days 1, 4, 8, 15, and 22 of the 28-day cycle.
- -Cycles 2 and 3: Days 1, 8, 15, and 22 of each 28-day cycle.
- -Cycle 4 and beyond: Days 1 and 15 of each 28-day cycle.
Monjuvi should be given in combination with lenalidomide for up to 12 cycles, after which it can be continued as monotherapy until disease progression or unacceptable toxicity occurs.
Warning & Precautions
Infusion-Related Reactions: Monjuvi 200 mg can cause infusion-related reactions. Premedicate patients before starting the infusion and monitor them closely during the process.
Myelosuppression: Tafasitamab-cxix can lead to severe myelosuppression, including thrombocytopenia, neutropenia, and anemia. Regularly monitor complete blood counts (CBC) before each treatment cycle and throughout therapy. Check patients with neutropenia for signs of infection.
Infections: Serious and potentially fatal infections, including opportunistic infections, have been reported during and after treatment with Monjuvi. Monitor patients for signs and symptoms of infection and manage them appropriately.
Fetal Risk: Tafasitamab-cxix may cause fetal B-cell depletion if given to a pregnant woman. Inform pregnant women about the potential risk to the fetus. Advise women of reproductive age to use effective contraception during treatment and for at least 3 months after the final dose.
Documentation Availability
Documents required to import MONJUVI to India?
MONJUVI (tafasitamab-cxix) can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing MONJUVI (Cancer Treatment Medicines) from around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the generic name for the trade name drug Monjuvi®?
The generic name for Monjuvi® is tafasitamab-cxix.
Who manufactures Monjuvi®?
Monjuvi® is manufactured by Morphosys US Inc.
Is Monjuvi® FDA approved?
Yes, Monjuvi® was approved by the FDA on July 31, 2020.
What is Monjuvi®?
Monjuvi® is a prescription medication used in combination with lenalidomide to treat adult patients with certain types of diffuse large B-cell lymphoma (DLBCL) that have relapsed or are refractory and who are not eligible for stem cell transplant.
What dosage and form is Monjuvi® available in?
Monjuvi® is available as an injection: 200 mg of tafasitamab-cxix in a lyophilized powder form, supplied in a single-dose vial for reconstitution.
What are the most common side effects of Monjuvi®?
Common side effects of Monjuvi® include decreased appetite, neutropenia, fatigue, anemia, cough, diarrhea, thrombocytopenia, fever, peripheral edema, and respiratory tract infection.
What are the storage conditions for Monjuvi®?
Store Monjuvi® refrigerated at 36-46°F (2-8°C) in its original carton to protect it from light. Do not shake or freeze it.
Is it safe to buy Monjuvi® online in India?
Yes, you can safely purchase Monjuvi® online in India through https://rx4u.in/.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
